Fulveskal
Brand Name: Fulveskal
Generic Name: Fulvestrant
Active
Registration Number
DR-XY48996
Dosage Form
Solution for Injection (IM)
Issuance Date
February 2, 2024
Expiry Date
February 2, 2029
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength50 mg/mL (250 mg/5 mL)
Packaging5 mL Type I Colorless Transparent Glass Pre-Filled Syringe with Luer Tip and Cap, Gray Fluoropolymer coated Bromobutyl Rubber Plunger Rod and 5 mL Plastic Back Stop + 21G x 1 1/2 TW Sterile safety glide. needle in PET Tray (Box of 2's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Anti-estrogen (Endocrine Therapy)
A
Application
Initial
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
FulvestrantActive
Monograph: Fulvestrant